Results 91 to 100 of about 8,147 (216)

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer [PDF]

open access: yes
Objectives: Hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly recognized as an effective addition to cytoreductive surgery in advanced ovarian cancer, particularly in patients who respond to platinum-based chemotherapy.
Chiantera, Vito   +10 more
core   +1 more source

Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence. [PDF]

open access: yes, 2018
Secondary and tertiary cytoreductive surgery was associated with improved overall survival in platinum-sensitive recurrent ovarian cancer (ROC). Hyperthermic intraoperative intra-peritoneal chemotherapy (HIPEC) is considered an attractive method in the ...
Ronsini C.   +12 more
core   +1 more source

Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study

open access: yesInternational Journal of Hyperthermia, 2020
Background and Objectives Postoperative thromboembolism is a significant cause of prolonged recovery in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mari Tuovila   +6 more
doaj   +1 more source

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC [PDF]

open access: yes, 2010
Bolnik s peritonealno karcinozo, zdravljen s sistemsko kemoterapijo, ima slabo napoved in preživetje nekaj mesecev. V zadnjih letih je postala hipertermična intraperitonealna kemoterapija (HIPEC) po popolni kirurški odstranitvi tumorja možen način ...
Barbka Novak
core  

Perioperatives Management im Rahmen der CRS und HIPEC [PDF]

open access: yes, 2018
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are therapeutic options for the treatment of intra-abdominal neoplasms.
Sinner, B., Bleiler, S., Bleiler, D.
core   +1 more source

Cytoreductuctive surgery and HIPEC

open access: yes, 2017
Systemic treatment alone is no longer appropriate for patients with limited peritoneal dissemination from primary or recurrent colon cancer. A clinical pathway for the management of these patients should include cytoreductive surgery and HIPEC. There are four specific problems that have to be resolved in the future in order to improve survival of the ...
Kekez, Tihomir   +10 more
openaire   +3 more sources

HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer [PDF]

open access: yes, 2015
This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, specifically using cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC).
Braam, H.J.W.
core  

HIPEC-potilaan perioperatiivinen nestehoito [PDF]

open access: yes, 2017
HIPEC-hoitoa käytetään sytoreduktiivisen kirurgian yhteydessä potilaille, joilla on peritoneaalinen karsinoosi. Nestehoito on haastavaa pitkän leikkauksen, runsaiden nesteiden menetysten ja hypertermisen intraperitoneaalisen sytostaattihuuhtelun vuoksi ...
Liesto, Sonja
core  

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China

open access: yesOrphanet Journal of Rare Diseases
Background To explore the application value of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei (PMP). Methods We retrospectively analyzed the clinical data of 526 patients
Bing Wang   +5 more
doaj   +1 more source

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)

open access: yesActa Biomedica Scientifica
Background. The high prevalence of advanced forms of cancer currently requires new treatment approaches. Only modern high-tech surgical procedures can provide means for improving the results of treatment.The aim.
S. I. Radostev   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy